Abstract
Acute severe asthma is characterized by a state of airway inflammation and increased bronchiolar smoothmuscle tone that leads to increased resistance to expiration and lung hyperinflation. Despite the better knowledge of its pathophysiology, the incidence and severity of asthma in the last twenty years is increased worldwide, although with significant age and geographic variation. As a result, the number of patients requiring more intensive medical therapy has also increased. In the most severe cases, often referred to as near-fatal asthma, the institution of mechanical ventilation may be required. Volatile anesthetics have bronchodilator effects on the bronchial smooth muscle. The use of inhalational anesthetic agents for treatment of severe status asthmaticus has been documented in case reports, case series and small uncontrolled studies. Their use may be considered in any mechanically ventilated patients whose severe bronchospasm failed to respond to maximal medical treatment. In the present review article, we aim to provide a brief description of the physio-pathological and clinical features of acute severe asthma, and of the principles of treatment, focusing our attention on the use of the inhalational anesthetics in severe patients requiring mechanical ventilation and not responding to conventional therapy.
Keywords: Status asthmaticus, near-fatal asthma, inhalational anesthetics, halothane, isoflurane, sevoflurane
Current Drug Targets
Title: Inhalational Anesthetics in Acute Severe Asthma
Volume: 10 Issue: 9
Author(s): R. Vaschetto, E. Bellotti, E. Turucz, C. Gregoretti, F. Della Corte and P. Navalesi
Affiliation:
Keywords: Status asthmaticus, near-fatal asthma, inhalational anesthetics, halothane, isoflurane, sevoflurane
Abstract: Acute severe asthma is characterized by a state of airway inflammation and increased bronchiolar smoothmuscle tone that leads to increased resistance to expiration and lung hyperinflation. Despite the better knowledge of its pathophysiology, the incidence and severity of asthma in the last twenty years is increased worldwide, although with significant age and geographic variation. As a result, the number of patients requiring more intensive medical therapy has also increased. In the most severe cases, often referred to as near-fatal asthma, the institution of mechanical ventilation may be required. Volatile anesthetics have bronchodilator effects on the bronchial smooth muscle. The use of inhalational anesthetic agents for treatment of severe status asthmaticus has been documented in case reports, case series and small uncontrolled studies. Their use may be considered in any mechanically ventilated patients whose severe bronchospasm failed to respond to maximal medical treatment. In the present review article, we aim to provide a brief description of the physio-pathological and clinical features of acute severe asthma, and of the principles of treatment, focusing our attention on the use of the inhalational anesthetics in severe patients requiring mechanical ventilation and not responding to conventional therapy.
Export Options
About this article
Cite this article as:
Vaschetto R., Bellotti E., Turucz E., Gregoretti C., Corte Della F. and Navalesi P., Inhalational Anesthetics in Acute Severe Asthma, Current Drug Targets 2009; 10 (9) . https://dx.doi.org/10.2174/138945009789108747
DOI https://dx.doi.org/10.2174/138945009789108747 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Attention Deficit and Hyperactivity Disorder: Controversies of Diagnosis and Safety of Pharmacological and Nonpharmacological Treatment
Current Drug Safety A High Accumulation of Hair Minerals in Mongolian People: 2nd Report; Influence of Manganese, Iron, Lead, Cadmium and Aluminum to Oxidative Stress, Parkinsonism and Arthritis
Current Aging Science Glucocorticoid Osteoporosis
Current Pharmaceutical Design Cysteinyl-Leukotriene Receptor Antagonists: Present Situation and Future Opportunities
Current Medicinal Chemistry Bedside Lung Ultrasound in the Care of the Critically Ill
Current Respiratory Medicine Reviews Molecular Basis of the Anti-Inflammatory Effects of Terpenoids
Inflammation & Allergy - Drug Targets (Discontinued) Discrete Modelling of Powder Dispersion in Dry Powder Inhalers - A Brief Review
Current Pharmaceutical Design Synthesis and Biological Applications of Triazole Derivatives – A Review
Mini-Reviews in Organic Chemistry The Clinical Role of N-acetylcysteine in the Management of COPD: A Review of Recent Literature
Current Respiratory Medicine Reviews Subject Index to Volume 2
Current Drug Targets - Inflammation & Allergy Crystal Structures of Phosphodiesterases and Implications on Substrate Specificity and Inhibitor Selectivity
Current Topics in Medicinal Chemistry Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Current Drug Targets Matrix Metalloproteinases in Respiratory Diseases: From Pathogenesis to Potential Clinical Implications
Current Medicinal Chemistry Human Exposure to Endocrine Disruptors and Breast Milk
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections
Recent Patents on Drug Delivery & Formulation Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Aerosol Delivery Devices for the Treatment of Adult Patients in Acute and Critical Care
Current Pharmaceutical Biotechnology QSAR Study On 5-Lipoxygenase Inhibitors Based on Support Vector Machine
Medicinal Chemistry The Effects of Statin Therapy on the Human Airway
Drug Metabolism Letters